1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Amentia in 3 studies
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lang, AE | 1 |
| Blair, RD | 1 |
| Fog, R | 1 |
| Nakamura, S | 1 |
| Fukuda, H | 1 |
| Hara, K | 1 |
| Fukuyama, H | 1 |
| Kameyama, M | 1 |
2 reviews available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Amentia
| Article | Year |
|---|---|
Parkinson's disease in 1984: an update.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Animals; Dementia; Drug Therapy, Combination; Dy | 1984 |
Neuronal uridine metabolism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Dementia; Female; Humans; Male; Mice; | 1992 |
1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Amentia
| Article | Year |
|---|---|
Biochemical aspects of Parkinson-dementia complex.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dement | 1988 |